Cytokinetics, Incorporated (NASDAQ:CYTK) Director Sells $17,743.50 in Stock
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 450 shares of the company’s stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $39.43, for a total value of $17,743.50. Following the transaction, the director now directly owns 14,658 shares of the […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 450 shares of the company’s stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $39.43, for a total value of $17,743.50. Following the transaction, the director now directly owns 14,658 shares of the […]